Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1409]

New AI ‘shapeshift’ test identifies women with ‘very high risk’ ovarian cancer

New AI ‘shapeshift’ test identifies women with ‘very high risk’ ovarian cancer

AI approach outperformed human experts in identifying cervical precancer

AI approach outperformed human experts in identifying cervical precancer

CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer

CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer

Genetics may influence the effects of vitamin E on cancer risk

Genetics may influence the effects of vitamin E on cancer risk

Olaparib approved by FDA for first-line maintenance therapy in BRCA-mutated advanced ovarian cancer

Olaparib approved by FDA for first-line maintenance therapy in BRCA-mutated advanced ovarian cancer

HPV discovery raises hope for new cervical cancer treatments

HPV discovery raises hope for new cervical cancer treatments

New epigenetic cervical cancer test has 100 per cent detection rate

New epigenetic cervical cancer test has 100 per cent detection rate

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients with DCIS, LCIS, and ADH

SABCS 2018: Low-dose tamoxifen was safe and effective at reducing recurrence and new breast disease for patients...

Last Month in Oncology with Dr. Bishal Gyawali: November 2018

Last Month in Oncology with Dr. Bishal Gyawali: November 2018

Sugar supplement slows tumor growth and can improve cancer treatment

Sugar supplement slows tumor growth and can improve cancer treatment

More from ecancer